Join us on Wednesday, October 20th, during the 52nd Union World Conference on Lung Health, for a virtual satellite session, co-chaired by Dr. Tereza Kasaeva, Director of the World Health Organization Global TB Programme, and Dr. Alaine Umubyeyi Nyaruhirira, Principal Technical Advisor for Laboratory Services at MSH, and featuring Marian W. Wentworth, CEO and President of MSH.
MSH is pleased to participate in the 51st Union World Conference on Lung Health, October 20-24, 2020 under the theme ‘Advancing Prevention. Committed to ending TB by 2030, the global community has set ambitious targets for countries to achieve by 2022: successfully treat 40 million people with TB and provide TB preventive therapy for at least 30 million people.With a presence in 19 of USAID’s 23 TB high-priority countries, MSH is ready to accelerate and expand our locally led efforts to eliminate TB.Learn more about MSH’s new TB projectsOur approach strengthens hea
The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) is holding an end-of-program event on March 1, in Arlington, VA.
We’ll be discussing progress made toward ensuring that quality, life-saving essential medicine and services are available and affordable to those who need them. We’ll also explore goals and challenges for the future of pharmaceutical systems strengthening and advance a vision of what it takes to build resilient, responsive pharmaceutical systems that promote good health outcomes.
Join MSH and our partners at the 47th Union World Conference on Lung Health in Liverpool, United Kingdom, October 26-29, 2016. Events include exclusive sneak peek at "The Lucky Specials," a movie demystifying TB, more than 60 posters and 13 oral presentations, 7 symposiums and workshops, our exhibit hall booth (number 34), and more.
Why are some children unresponsive to treatment for pneumonia, malnutrition and HIV? Why do some of them die? Maybe they are among the over 600,000 children that fall ill with tuberculosis each year but are never diagnosed. Join experts from the TB and MNCH communities in a global debate on the linkages between tuberculosis and maternal and child health.
Join the seminar at Leadernet.org
Tuberculosis (TB) kills more people than any other single infectious agent, claiming 1.5 million lives per year. More than 13 million people in the US have TB infection, yet it is often a hidden disease.
At this briefing we will hear from TB survivors about their experience, the lessons learned, and what the US needs to do to defeat this disease. Join us as we commemorate World TB Day and thank these survivors for coming forward to tell their stories.
Can't join in person? Follow @MSHActs for live coverage of this #WorldTBDay event.
The White House recently launched the National Action Plan for Combating Multidrug-Resistant Tuberculosis (MDR-TB) which aims to treat 35 percent of all MDR-TB patients in the 10 countries with the highest TB burden by 2018. TB has caused more deaths than any other single infectious disease worldwide. Over the past 20 years the number of people who develop TB has declined annually, but the development and spread of MDR-TB can easily erode and reverse this significant progress. MDR-TB is resistant to the two most potent TB drugs and treatment is significantly more expensive; it presents a major challenge to the health system and pushes people into poverty. This panel and reception event will delve deeper into some of the specifics of tackling MDR-TB in high-burden environments, with a focus on the successful implementation of proven strategies. Join us as we discuss what is working, what lessons can be learned and applied in other settings, the challenges that remain, and innovative ways to tackle them.
Health systems strengthening drives our response to the tuberculosis epidemic. In over 30 countries MSH is working with international, national, and local partners to strengthen the capacity of health systems, national TB programs, and health managers to improve the lives of those affected by TB and prevent the spread of disease. Our work addresses all elements of the health system: service delivery; leadership and governance; medical products, vaccines, and technologies; health financing; health information; and human resources.
RSVP required to email@example.com. Lunch will be served.
Tuberculosis (TB) kills 1.5 million people a year, mainly spread by coughing. From 8 to 10 million people in the US have TB infection. Drug resistance is growing globally, but TB programs are achieving impressive results by engaging with the community. How can we beat TB? How can we move faster to end TB deaths?
Moderator: John Fawcett, Legislative Director, RESULTS
The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, led by Management Sciences for Health (MSH), in collaboration with the Stop TB Partnership Global Drug Facility, will host a technical conference titled, “Building the Post-2015 Agenda: Novel Approaches to Improving Access to TB Medicines and Pharmaceutical Services” from March 2-6, 2015 at the Conrad Bangkok Hotel in Bangkok, Thailand.
Fighting Drug-Resistant TB in the 21st Century: Novel Approaches to Improving Access to anti-TB Medicines and Pharmaceutical Services
1st Conference on Pharmaceutical Management for TB and M/XDR-TB for WHO European Region
Health systems stengthening drives our response to the tuberculosis epidemic. In over 30 countries MSH is working with international, national, and local partners to strengthen the capacity of health systems, national TB programs, and health managers to improve the lives of those affected by TB and prevent the spread of disease. Our work addresses all elements of the health system: service delivery; leadership and governance; medical products, vaccines, and technologies; health financing; health information; and human resources.
Join us during UN General Assembly (UNGA) week for a panel discussion with speakers from the NCD, Malaria, TB, Family Planning, and Reproductive Health communities and more!
Speakers include: Jeffrey Sachs, Director, Sustainable Development Solutions Network
Jeanette Vega, Managing Director, Rockefeller Foundation
Ariel Pablos-Mendez, Asst.Administrator, Global Health, US Agency for International Development (USAID)
Charles Nelson, Malaria Consortium Johanna Ralston, Director, NCD Alliance
Johanna Ralston, CEO, World Heart Federation; NCD Alliance Steering Group